Shearwood McClelland III, MD

Dr. McClelland (@TheDrWood) received his artium baccalaureus with honors in biology from Harvard College, and his medical degree from the Columbia University College of Physicians and Surgeons. A member of the NRG Oncology Health Disparities Scientific Core Committee, he has a more than 15-year publication track record of investigating disparities in healthcare access and their subsequent impact on patient outcomes. Dr. McClelland has also published extensively on radiation-based modalities for treatment of central nervous system disease, and has authored several manuscripts utilizing population-based databases for both adult and pediatric conditions.

A four-time winner of the Conquer Cancer Foundation of ASCO Merit Award from the American Society of Clinical Oncology and two-time winner of the Trainee Research Prize from the Radiological Society of North America, Dr. McClelland has also received the Young Oncologist Travel Award from the American Radium Society, the Young Investigator Award from the American Epilepsy Society, and the Cone Pevehouse Award from the American Association of Neurological Surgeons among numerous national awards.

His work has been presented at more than 30 national and international scientific meetings including the American Society of Clinical Oncology, the American Society for Radiation Oncology, American Radium Society, International Stereotactic Radiosurgery Society, Society for Neuro-Oncology, American Epilepsy Society, SpineWeek, International Epilepsy Symposium, American Association of Neurological Surgeons, Congress of Neurological Surgeons, National Medical Association, Southern Neurosurgical Society, North American Spine Society, and the Radiological Society of North America.

Creator of the Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI) multicenter prospective clinical trial (clinicaltrials.gov number NCT04047602), the Navigator-Assisted Hypofractionation (NAVAH) program, and the Advances in Radiation Oncology’s Radiation Oncology Disparities in North America article series, Dr. McClelland has published more than 160 articles (including more than 130 first-author publications) in peer-reviewed journals including The Lancet, JAMA Oncology, and The Lancet Oncology.

Editorial Board (Neuro-Oncology)
Terms of Appointment: August 2019 - July 2021;  August 2021 - July 2023;  August 2023 - July 2025